|
|
Rockeby Biomed Ltd - Comparative Business Analysis Snapshot
Business Description
Rockeby Biomed Ltd. The Group's principal activities are researching, developing and marketing rapid testing technologies for infectious disease in humans and animals and lifestyle health products including CanDia5 and Avian Influenza Virus test kits. It operates in Australia, Asia Pacific, Europe, Middle East and Africa.
Competitor Analysis
This analysis compares Rockeby Biomed Ltd with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
